Multicenter study of ceftolozane/tazobactam for treatment of Pseudomonas aeruginosa infections in critically ill patients.
Balandin B, Ballesteros D, Ruiz de Luna R, López-Vergara L, Pintado V, Sancho-González M, Soriano-Cuesta C, Pérez-Pedrero MJ, Asensio-Martín MJ, Fernández-Simón I, Rodríguez-Serrano D, Silva A, Chicot M, Iranzo R, Martínez-Sagasti F, Royuela A.
Balandin B, et al. Among authors: fernandez simon i.
Int J Antimicrob Agents. 2021 Mar;57(3):106270. doi: 10.1016/j.ijantimicag.2020.106270. Epub 2021 Jan 19.
Int J Antimicrob Agents. 2021.
PMID: 33347991